Global Patent Index - EP 0926955 A4

EP 0926955 A4 20030507 - CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER

Title (en)

CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER

Title (de)

KONJUGATE NÜTZLICH IN DIE BEHANDLUNG VON PROSTATAKARZINOM

Title (fr)

CONJUGUES UTILES DANS LE TRAITEMENT DU CANCER DE LA PROSTATE

Publication

EP 0926955 A4 20030507 (EN)

Application

EP 97942423 A 19970910

Priority

  • GB 9624170 A 19961119
  • US 9716087 W 19970910
  • US 2601596 P 19960912

Abstract (en)

[origin: WO9810651A1] Chemical conjugates which comprise oligopeptides, having amino acid sequences that are selectively proteolytically cleaved by free prostate specific antigen (PSA), hydrophilic oligopeptide blocking groups and known cytotoxic agents are disclosed. Such conjugates are useful in the treatment of prostatic cancer and benign prostatic hypertrophy (BPH).

IPC 1-7

A61K 47/48; A01N 37/18; A61K 38/00; A61K 38/28; A61K 38/16

IPC 8 full level

A61K 35/00 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 47/48 (2006.01); C07K 5/107 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01)

CPC (source: EP)

A61K 47/65 (2017.07); C07K 5/1016 (2013.01); C07K 7/06 (2013.01); C07K 14/47 (2013.01); A61K 38/00 (2013.01)

Citation (search report)

  • No further relevant documents disclosed
  • See references of WO 9810651A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

DOCDB simple family (publication)

WO 9810651 A1 19980319; AU 4412397 A 19980402; AU 715632 B2 20000203; CA 2265476 A1 19980319; EP 0926955 A1 19990707; EP 0926955 A4 20030507; JP 2001501601 A 20010206

DOCDB simple family (application)

US 9716087 W 19970910; AU 4412397 A 19970910; CA 2265476 A 19970910; EP 97942423 A 19970910; JP 51385798 A 19970910